Recent summary of changes to the LAM

The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.

Additions

Bimatoprost eye drops 0.03%
Brinzolamide + brimonidine eye drop 1% + 0.2%
Brinzolamide + timolol eye drops 1% + 0.5%
Brinzolamide eye drop 1%
Carbetocin Injection 100 microgram/mL
Carbomer 980 eye drops 0.2%, 0.6mL x 30 ’minims’
Ciprofloxacin eye drops 0.3%
Elranatamab injection (subcutaneous) 44 mg/1.1 mL, 76 mg/1.9 mL
Esketamine nasal spray 28 mg/2 actuations
Mometasone nasal spray 50 microgram/actuation
Tamsulosin modified release tablet 400 microgram
Teprotumumab injection 500 mg

Amendments

Aflibercept Injection 2 mg/0.05 mL (3.6 mg/0.09 mL) syringe
Aflibercept Injection 8 mg/0.07 mL (21 mg/0.184 mL), syringe
Aflibercept Injection 8 mg/0.07 mL (30.1 mg/0.263 mL), vial
Amphotericin B lozenge 10mg
Dorzolamide + timolol eye drop 2% + 0.5%
Dorzolamide eye drop 2%
Estradiol modified release pessary 10 microgram
Latanoprost + timolol eye drop 0.005% + 0.5%
Latanoprost eye drop 0.005%
Lidocaine Gel 2% Syringe
Mifepristone & Misoprostol (combination pack - 200 mg & 200 microgram [MS 2-Step®])
Mupirocin 2% nasal ointment 5g
Timolol eye drop 0.5%
Travoprost + timolol eye drop 0.004% + 0.5%
Travoprost eye drop 0.004%

Deletions

Aflibercept injection 2 mg/0.05 mL (4 mg/0.1 mL) vial
Apraclonidine eye drop 0.5%, 10 mL
Artificial saliva liquid 2 Litres
Betaxolol eye drops 0.5%
Carbachol eye drops 1.5% 15mL
Carbochol eye drops 3%
Pilocarpine eye drops 0.125% 15mL
Pilocarpine eye drops 3%
Sodium cromoglycate 2% eye drops
Timolol eye drop 0.25%

Last updated: 9 November 2026